![Olivier Bataille](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Olivier Bataille
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MY01, Inc.
![]() MY01, Inc. Medical SpecialtiesHealth Technology MY01, Inc. is a Canadian healthcare technology company that aims to improve patient outcomes by providing objective data to aid in the diagnosis of compartment syndrome. MY01 is based in an undisclosed location since 2015 and leverages its expertise in microsensing technology to provide innovative diagnostic solutions. The company believes that adding actionable, quantitative data at the bedside can augment clinical assessments to provide more effective care. The company was founded in 2015 by Charles Allan, George Xereas, and Edward Harvey, with Charles Allan serving as the CEO since then. | Operationeel Directeur | 01-05-2019 | - |
Loopbaan van Olivier Bataille
Eerdere bekende functies van Olivier Bataille
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CryoCath Technologies, Inc.
![]() CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Operationeel Directeur | - | - |
Statistieken
Internationaal
Canada | 3 |
Operationeel
Chief Operating Officer | 2 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
CryoCath Technologies, Inc.
![]() CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
MY01, Inc.
![]() MY01, Inc. Medical SpecialtiesHealth Technology MY01, Inc. is a Canadian healthcare technology company that aims to improve patient outcomes by providing objective data to aid in the diagnosis of compartment syndrome. MY01 is based in an undisclosed location since 2015 and leverages its expertise in microsensing technology to provide innovative diagnostic solutions. The company believes that adding actionable, quantitative data at the bedside can augment clinical assessments to provide more effective care. The company was founded in 2015 by Charles Allan, George Xereas, and Edward Harvey, with Charles Allan serving as the CEO since then. | Health Technology |
- Beurs
- Insiders
- Olivier Bataille
- Ervaring